FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 37 filers reported holding FATE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $169,000 | -17.2% | 67,239 | +2.6% | 0.00% | – |
| Q3 2016 | $204,000 | +59.4% | 65,539 | -13.3% | 0.00% | – |
| Q2 2016 | $128,000 | +18.5% | 75,572 | +26.2% | 0.00% | – |
| Q1 2016 | $108,000 | -50.5% | 59,871 | -7.3% | 0.00% | – |
| Q4 2015 | $218,000 | -34.5% | 64,611 | +3.3% | 0.00% | – |
| Q3 2015 | $333,000 | -19.8% | 62,538 | -2.6% | 0.00% | – |
| Q2 2015 | $415,000 | +277.3% | 64,194 | +186.5% | 0.00% | – |
| Q1 2015 | $110,000 | -8.3% | 22,406 | -6.4% | 0.00% | – |
| Q4 2014 | $120,000 | +6.2% | 23,926 | +7.7% | 0.00% | – |
| Q3 2014 | $113,000 | -24.7% | 22,216 | -6.8% | 0.00% | – |
| Q2 2014 | $150,000 | -33.3% | 23,831 | +2.9% | 0.00% | – |
| Q1 2014 | $225,000 | – | 23,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |